SCHEMBL28021161

SCHEMBL28021161

[c]1cc2c3c(cccc3c1)N=CN2

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK6 P43250 1/20 0.66
GAA P10253 4/20 0.34
MAPT P10636 4/20 0.34
MCL1 Q07820 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
APAF1 O14727 1/20 0.32
USP2 O75604 1/20 0.32
PLCG1 P19174 1/20 0.32
CCR6 P51684 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28021513 0.86 GRK6 (0.66) GRK6GAAMAPTMCL1CYP1A2
SCHEMBL8112 0.80 GRK6 (1.00) GRK6GAAMAPTMCL1CYP1A2
SCHEMBL29778809 0.80 GRK6 (1.00) GRK6GAAMAPTMCL1CYP1A2
Bromide SCHEMBL31741343 0.78 GRK6 (0.96) GRK6GAAMAPTMCL1CYP1A2
Hydrochloric Acid SCHEMBL11423019 0.78 GRK6 (0.96) GRK6GAAMAPTMCL1CYP1A2
Formaldehyde SCHEMBL27694578 0.75 GRK6 (0.89) GRK6GAAMAPTMCL1CYP1A2
Benzoquinone SCHEMBL28256504 0.71 GRK6 (0.80) GRK6GAAMAPTMCL1CYP1A2
SCHEMBL27475210 0.69 GRK6 (0.75) GRK6GAAMAPTMCL1CYP1A2
SCHEMBL27746989 0.69 GRK6 (0.75) GRK6GAAMAPTMCL1CYP1A2
Naphthoquinone SCHEMBL28258043 0.67 GRK6 (0.71) GRK6GAAMAPTMCL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109475551-A Anti-EGFR Combinations for the Treatment of Tumors 博笛生物科技有限公司 2019-03-15 CN disclosed
CN-109414497-A Anti- HER2 for treating tumour is combined 博笛生物科技有限公司 2019-03-01 CN disclosed
CN-107074959-A Anti- PD L1 conjugates for treating tumour 博笛生物科技有限公司 2017-08-18 CN disclosed
CN-107074958-A Anti- PD L1 for treating tumour are combined 博笛生物科技有限公司 2017-08-18 CN disclosed
CN-106943596-A anti-CD 20 combination for use in the treatment of tumors 博笛生物科技(北京)有限公司 2017-07-14 CN disclosed
CN-106943598-A anti-HER 2 combination for treating tumors 博笛生物科技(北京)有限公司 2017-07-14 CN disclosed
CN-106535938-A Combination therapeutic compositions and combination therapeutic methods for treating cancer 上海博笛生物科技有限公司 2017-03-22 CN disclosed
CN-105899539-A Compounds and compositions for immunotherapy 博笛生物科技(北京)有限公司 2016-08-24 CN disclosed
CN-105899537-A Compounds and compositions targeting EGFR expressing tumors 博笛生物科技(北京)有限公司 2016-08-24 CN disclosed
CN-105899538-A Compounds and compositions targeting HER2 positive tumors 博笛生物科技(北京)有限公司 2016-08-24 CN disclosed
CN-105440135-A Anti-PD-L1 conjugates for the treatment of tumors BODI BIOTECHNOLOGY CO LTD 2016-03-30 CN disclosed
CN-105233291-A Combination therapeutic compositions and combination therapeutic methods for treating cancer BIRDLE BIOTECH INC 2016-01-13 CN disclosed
CN-104861063-A HER2 positive tumor targeting compound and composition thereof BIRDLE BIOTECH INC 2015-08-26 CN disclosed
CN-104861067-A Compound for immunotherapy, and composition BIRDLE BIOTECH INC 2015-08-26 CN disclosed
CN-104861064-A EGFR-expressing tumor targeting compound and composition thereof BIRDLE BIOTECH INC 2015-08-26 CN disclosed